CD19 and B-cell chronic lymphocytic leukemia: In a recent phase I/II trial, 11 patients with R/R CD19+ non-Hodgkin lymphoma or chronic lymphocytic leukemia were administered with HLA-mismatched anti-CD19 CAR NK cells derived from cord blood (NCT03056339).